4
Changes in Ownership
Immunome Inc. Filed Acc 0001993684-26-000008
Chief Scientific Officer sold 13,200 shares at $25.32 ($334,224)
- Chief Scientific Officer acquired 18,000 shares (option exercise)
- Chief Scientific Officer gave 8,800 shares (gift)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Higgins Jack Chief Scientific Officer | 2026-09-11 | Option exercise 10b5-1 | +18,000 | $1.35 | $24,300 | 78,250 | D: show line 1 in the form |
| Higgins Jack Chief Scientific Officer | 2026-09-11 | Sale 10b5-1 | −13,200 | $25.32 | $334,224 | 65,050 | D: show line 2 in the form |
| Higgins Jack Chief Scientific Officer | 2026-09-11 | Gift 10b5-1 | −8,800 | 56,250 | D: show line 3 in the form | ||
| Open-market sales · 13,200 sh · avg $25.32 · $334,224 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Higgins Jack Chief Scientific Officer | 2026-09-11 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | +18,000 | 133,840 | D: show line 4 in the form |
Loading xslF345X06/form4-09152026_040933.xml…